Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Johnson

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
ACS Infectious Diseases|December 27, 2018
Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis TherapyBryna L Fitzgerald, M Nurul Islam, Barbara Graham, et al.
Tuberculosis (Edinburgh, Scotland)|March 26, 2014
How we determined the most reliable solid medium for studying treatment of tuberculosisCharles M Heilig, Pei-Jean I Feng, Moses L Joloba, et al.
Tuberculosis (Edinburgh, Scotland)|April 5, 2014
What is the most reliable solid culture medium for tuberculosis treatment trials?Moses L Joloba, John L Johnson, Pei-Jean I Feng, et al.
The Journal of Infectious Diseases|August 6, 2004
A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosisAlison M Elliott, Henry Luzze, Maria A Quigley, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary TuberculosisAbdullah Alsultan, Jennifer J Furin, Jeannine Du Bois, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Early Bactericidal Activity of AZD5847 in Patients with Pulmonary TuberculosisJennifer J Furin, Jeannine Du Bois, Elana van Brakel, et al.
Annals of the American Thoracic Society|March 20, 2013
The association between symptoms and microbiologically defined response to tuberculosis treatmentCraig M Hales, Charles M Heilig, Richard Chaisson, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2008
Early and extended early bactericidal activity of linezolid in pulmonary tuberculosisReynaldo Dietze, David Jamil Hadad, Bryan McGee, et al.
Nature Immunology|July 27, 2021
Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulationMohamed S Abdel-Hakeem, Sasikanth Manne, Jean-Christophe Beltra, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2019
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis PatientsSimone H J van den Elsen, Marieke G G Sturkenboom, Onno W Akkerman, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
ACS Infectious Diseases|December 27, 2018
Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis TherapyBryna L Fitzgerald, M Nurul Islam, Barbara Graham, et al.
Tuberculosis (Edinburgh, Scotland)|March 26, 2014
How we determined the most reliable solid medium for studying treatment of tuberculosisCharles M Heilig, Pei-Jean I Feng, Moses L Joloba, et al.
Tuberculosis (Edinburgh, Scotland)|April 5, 2014
What is the most reliable solid culture medium for tuberculosis treatment trials?Moses L Joloba, John L Johnson, Pei-Jean I Feng, et al.
The Journal of Infectious Diseases|August 6, 2004
A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosisAlison M Elliott, Henry Luzze, Maria A Quigley, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary TuberculosisAbdullah Alsultan, Jennifer J Furin, Jeannine Du Bois, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Early Bactericidal Activity of AZD5847 in Patients with Pulmonary TuberculosisJennifer J Furin, Jeannine Du Bois, Elana van Brakel, et al.
Annals of the American Thoracic Society|March 20, 2013
The association between symptoms and microbiologically defined response to tuberculosis treatmentCraig M Hales, Charles M Heilig, Richard Chaisson, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2008
Early and extended early bactericidal activity of linezolid in pulmonary tuberculosisReynaldo Dietze, David Jamil Hadad, Bryan McGee, et al.
Nature Immunology|July 27, 2021
Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulationMohamed S Abdel-Hakeem, Sasikanth Manne, Jean-Christophe Beltra, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2019
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis PatientsSimone H J van den Elsen, Marieke G G Sturkenboom, Onno W Akkerman, et al.
Pageof 11